Therapeutic Approach

Archive: November, 2015

Ritter Pharmaceuticals Provides Third Quarter 2015 Financial Results and Business Update

LOS ANGELES (November 17, 2015) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today reported financial results and a business update for the third quarter ended September 30, 2015. Recent Highlights – Closed initial public […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD